(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
2 days till quarter result
(amc 2024-05-06)
Expected move: +/- 7.71%
@ $15.16
发出时间: 14 Feb 2024 @ 22:42
回报率: -5.84%
上一信号: Feb 13 - 03:20
上一信号:
回报率: -2.51 %
Live Chart Being Loaded With Signals
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States...
Stats | |
---|---|
今日成交量 | 122 095 |
平均成交量 | 288 895 |
市值 | 339.17M |
EPS | $0 ( 2024-02-20 ) |
下一个收益日期 | ( $-0.110 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 11.61 |
ATR14 | $0.0170 (0.12%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-27 | Burns Kristie | Sell | 1 091 | Common Stock |
2024-02-29 | Burns Kristie | Sell | 243 | Common Stock |
2024-02-27 | Reuvers Daniel L. | Sell | 4 689 | Common Stock |
2024-02-29 | Reuvers Daniel L. | Sell | 1 396 | Common Stock |
2024-02-24 | Reuvers Daniel L. | Buy | 13 100 | Common Stock |
INSIDER POWER |
---|
80.60 |
Last 93 transactions |
Buy: 671 413 | Sell: 92 622 |
音量 相关性
Tactile Systems 相关性 - 货币/商品
Tactile Systems 财务报表
Annual | 2023 |
营收: | $274.42M |
毛利润: | $195.13M (71.11 %) |
EPS: | $1.240 |
FY | 2023 |
营收: | $274.42M |
毛利润: | $195.13M (71.11 %) |
EPS: | $1.240 |
FY | 2022 |
营收: | $246.79M |
毛利润: | $175.98M (71.31 %) |
EPS: | $-0.890 |
FY | 2021 |
营收: | $208.06M |
毛利润: | $148.21M (71.24 %) |
EPS: | $-0.600 |
Financial Reports:
No articles found.
Tactile Systems
Tactile Systems Technology, Inc., a medical technology company, engages in the development and provision of medical devices for chronic diseases in the United States. The company offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre system, a portable pneumatic compression device that is used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; and AffloVest, a portable high frequency chest wall oscillation test for the treatment of retained pulmonary secretions such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders. The company was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。